TACC2 inhibitors belong to a class of chemical compounds that specifically target and modulate the activity of transforming acidic coiled-coil protein 2 (TACC2). TACC2 is a member of the TACC protein family, which plays a crucial role in mitotic spindle organization and chromosome segregation during cell division. These inhibitors are designed to interfere with the normal function of TACC2, which is essential for maintaining proper cell division and genomic stability. By selectively inhibiting TACC2, these compounds aim to disrupt the intricate machinery involved in mitosis, offering a potential avenue for controlling cell proliferation in various biological contexts.
TACC2 inhibitors involves binding to TACC2 and altering its function in the assembly and stabilization of microtubules within the mitotic spindle. Microtubules are dynamic structures critical for chromosome segregation, and their proper organization is essential for the accurate distribution of genetic material during cell division. TACC2 inhibitors may act by disrupting the interaction between TACC2 and other cellular components involved in microtubule regulation, leading to aberrant spindle formation and, ultimately, impaired cell division. The exploration of TACC2 inhibitors represents a significant area of research in understanding the intricacies of cell cycle regulation and may have implications for potential interventions in conditions where uncontrolled cell division is a hallmark feature.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds tubulin, inhibiting its polymerization which can affect TACC2's role in microtubule assembly. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Inhibits tubulin polymerization and can indirectly affect TACC2's microtubule-stabilizing activity. | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
Stabilizes microtubules and can affect TACC2 functionality by altering microtubule dynamics. | ||||||
Griseofulvin | 126-07-8 | sc-202171A sc-202171 sc-202171B | 5 mg 25 mg 100 mg | $85.00 $220.00 $598.00 | 4 | |
Binds to tubulin, interfering with microtubule function and potentially impacting TACC2-associated pathways. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Inhibits EGFR tyrosine kinase, potentially altering signaling pathways that may indirectly influence TACC2 activity. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Targets EGFR tyrosine kinase which might affect downstream signaling pathways involving TACC2. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Dual inhibitor of EGFR and HER2, potentially affecting TACC2 through altered signaling pathways. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multikinase inhibitor that could impact TACC2 function by modulating various signaling pathways. | ||||||